Susan G. Komen® | Understanding Breast Cancer | Breast Cancer Research | Table 39: Adjuvant chemotherapy and overall survival

Susan G. Komen® | Understanding Breast Cancer | Breast Cancer Research | Table 39: Adjuvant chemotherapy and overall survival

Adjuvant Chemotherapy After Preoperative (Chemo)Radiotherapy and Surgery for Patients With Rectal Cancer | PracticeUpdate

Adjuvant Chemotherapy After Preoperative (Chemo)Radiotherapy and Surgery for Patients With Rectal Cancer | PracticeUpdate

October 15, 2014 is BRA Day - Breast Reconstruction Awareness Day. An effort to increase awareness for women regarding their options for reconstruction & the best way to go about it when faced with a mastectomy & adjuvant chemotherapy.

October 15, 2014 is BRA Day - Breast Reconstruction Awareness Day. An effort to increase awareness for women regarding their options for reconstruction & the best way to go about it when faced with a mastectomy & adjuvant chemotherapy.

pin 2
heart 1
Non-Small Cell Lung Cancer Treatment Protocols: Treatment Recommendations, Early or Localized Disease, Chemoradiation Therapy, Locally Advanced Disease, First-Line Chemotherapy, Metastatic or Recurrent Disease

Non-Small Cell Lung Cancer Treatment Protocols: Treatment Recommendations, Early or Localized Disease, Chemoradiation Therapy, Locally Advanced Disease, First-Line Chemotherapy, Metastatic or Recurrent Disease

Adjuvant chemotherapy is used before any surgery to reduce the size of the tumor. In #adjuvant chemotherapy treatment, the patient recovers better and faster.

Adjuvant chemotherapy is used before any surgery to reduce the size of the tumor. In #adjuvant chemotherapy treatment, the patient recovers better and faster.

Adjuvant Chemotherapy Improves Survival in Bladder Cancer

Adjuvant Chemotherapy Improves Survival in Bladder Cancer

A new study has demonstrated that treatment with adjuvant paclitaxel and trastuzumab (Herceptin, Genentech) is highly effective in patients with stage I, node-negative, HER2-positive breast cancer. Although this finding comes from a Phase II trial, clinicians believe it will have a great influence on practice.

A new study has demonstrated that treatment with adjuvant paclitaxel and trastuzumab (Herceptin, Genentech) is highly effective in patients with stage I, node-negative, HER2-positive breast cancer. Although this finding comes from a Phase II trial, clinicians believe it will have a great influence on practice.

Pinterest • The world’s catalogue of ideas
Search